MarketPeel
Insider Trading Intelligence
GM

George Adi Mor

CMMB
CHIEF SCIENTIFIC OFFICER · CHEMOMAB THERAPEUTICS LTD. · CIK 0001851069
FILING MIX · LIFETIME33%/67%
BUYS
4
SELLS
8
TOTAL VALUE
$1.30M
COMPANIES
1
ACTIVE SINCE
Oct 2016
HOLDINGS NOW
134,205
AVG SELL PX
$2.15
TRADE KIND
SHOWING 12 / 12
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by George Adi Mor, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+100.00%-17.32%+2.16%-19.48%-19.48%
14d4+100.00%-15.43%+3.77%-19.20%-19.20%
30d4+100.00%-18.02%+3.40%-21.42%-21.42%
60d4+100.00%-21.87%+3.69%-25.55%-25.55%
90d4+100.00%-29.09%+6.58%-35.67%-35.67%
180d4+100.00%-40.78%+11.37%-52.15%-52.15%
1y4+100.00%-76.43%+20.31%-96.74%-96.74%
2y4+100.00%-27.04%+55.17%-82.22%-82.22%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CMMB · 134,205 shares · as of May 29, 2026
081,194162,388243,581324,7752017201820192020202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2016
2017
2017
2017
2017
2018
2018
2018
2018
2019
2019
2019
2019
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 4 buys / 8 sellsCOVERAGE · 39 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CMMB
CHEMOMAB THERAPEUTICS LTD.
SALE
Chief Executive Officer
4,878$2.05$10.0K134,205May 29, 2026Jun 1, 2026View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
SALE
Chief Executive Officer
18,75018,750May 29, 2026Jun 1, 2026View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
SALE
Chief Executive Officer
4,926$2.08$10.2K139,131May 29, 2026Jun 1, 2026View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
SALE
Chief Executive Officer
31,71231,712May 29, 2026Jun 1, 2026View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
SALE
Chief Scientific Officer
7,700$5.03$38.7K317,075Jan 3, 2023Jan 5, 2023View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
SALE
Chief Scientific Officer
6,100$5.03$30.7K251,147Jan 3, 2023Jan 5, 2023View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
SALE
Chief Scientific Officer
257,248$2.08$536.3K257,247Nov 16, 2022Nov 17, 2022View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
SALE
Chief Scientific Officer
324,775$2.08$677.1K324,775Nov 16, 2022Nov 17, 2022View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASEGRANT
Stock grant
131,698131,698Mar 15, 2018Jan 5, 2023View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASEGRANT
Stock grant
131,698131,698Mar 15, 2018Nov 17, 2022View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASEGRANT
Stock grant
33,72533,725Oct 28, 2016Jan 5, 2023View →
CMMB
CHEMOMAB THERAPEUTICS LTD.
PURCHASEGRANT
Stock grant
33,72533,725Oct 28, 2016Nov 17, 2022View →
Other insiders · CMMB
Loading peer insiders…
About this filer
CIK 0001851069
ROLE
Chief Scientific Officer
PRIMARY
CMMB
COMPANIES
1
ACTIVE SINCE
Oct 2016
MARKETPEEL · /INSIDER/0001851069DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback